Header cover image

Media Healthcare Sector

Results

2309

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,309 companies

Hellenic Dynamics

Market Cap: UK£1.4m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

HELD

UK£0.0095

7D

0%

1Y

-75.3%

Galera Therapeutics

Market Cap: US$1.8m

A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.

GRTX

US$0.024

7D

6.2%

1Y

-87.8%

OMID Holdings

Market Cap: US$1.8m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

OMID

US$0.018

7D

-15.9%

1Y

-38.3%

Aion Therapeutic

Market Cap: CA$2.5m

Engages in the health and wellness business in the United States.

AION

CA$0.005

7D

0%

1Y

-75.0%

VGI Health Technology

Market Cap: AU$2.8m

VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.

VTL

AU$0.02

7D

0%

1Y

n/a

Blueberries Medical

Market Cap: CA$2.5m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

BBM

CA$0.005

7D

-66.7%

1Y

-75.0%

Algernon Pharmaceuticals

Market Cap: CA$2.5m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

AGN

CA$0.09

7D

5.9%

1Y

-35.7%

1933 Industries

Market Cap: CA$2.5m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

TGIF

CA$0.005

7D

-50.0%

1Y

-66.7%

Lifeline Biotechnologies

Market Cap: US$1.7m

Operates as a medical technology company in the United States.

LLBO

US$0.0004

7D

-20.0%

1Y

0%

Medicine Man Technologies

Market Cap: US$1.7m

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

SHWZ

US$0.02

7D

0%

1Y

-96.1%

RespireRx Pharmaceuticals

Market Cap: US$1.7m

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

RSPI

US$0.0018

7D

157.1%

1Y

111.8%

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

PYC

UK£0.0042

7D

0%

1Y

-66.4%

Ayala Pharmaceuticals

Market Cap: US$1.7m

A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.

ADXS

US$0.034

7D

-14.8%

1Y

-84.5%

Imagion Biosystems

Market Cap: AU$2.6m

Provides medical imaging technologies using magnetic resonance.

IBX

AU$0.013

7D

8.3%

1Y

n/a

Binovi Technologies

Market Cap: CA$2.3m

Engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.

VISN.H

CA$0.085

7D

0%

1Y

n/a

City View Green Holdings

Market Cap: CA$2.3m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

CVGR

CA$0.005

7D

0%

1Y

0%

Protagenic Therapeutics

Market Cap: US$1.6m

A biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.

PTIX

US$3.03

7D

-2.6%

1Y

-85.6%

United American Healthcare

Market Cap: US$1.6m

Through its subsidiaries, provides contract manufacturing services to the medical device industry.

UAHC

US$0.014

7D

-18.2%

1Y

-44.4%

Rize Oncology

Market Cap: CA$2.3m

Engages in the development of oncology therapeutics.

RIZE

CA$0.03

7D

50.0%

1Y

-45.5%

Syra Health

Market Cap: US$1.6m

A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States.

SYRA

US$0.093

7D

12.6%

1Y

-94.1%

Helix BioMedix

Market Cap: US$1.6m

Operates as a specialty dermatology and consumer products skin health company in the United States.

HXBM

US$7.18

7D

0%

1Y

n/a

SOHM

Market Cap: US$1.6m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

SHMN

US$0.0008

7D

14.3%

1Y

-20.0%

Bio-Path Holdings

Market Cap: US$1.5m

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

BPTH

US$0.18

7D

13.5%

1Y

-91.4%

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

HMPG

CA$0.015

7D

0%

1Y

-72.7%

American Green

Market Cap: US$1.5m

Operates as a technology company in the medical cannabis industry in the United States.

ERBB

US$0.00035

7D

0%

1Y

-12.5%

MyndTec

Market Cap: CA$2.1m

A medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States.

MYTC

CA$0.08

7D

0%

1Y

-20.0%

GelStat

Market Cap: US$1.5m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

GSAC

US$0.0004

7D

0%

1Y

33.3%

CBD of Denver

Market Cap: US$1.5m

Engages in developing and commercializing cannabidiol (CBD) products.

CBDD

US$0.00015

7D

0%

1Y

-84.4%

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

WIB

CA$0.13

7D

0%

1Y

4.0%

Procyon

Market Cap: US$1.5m

Manufactures and markets wound and skin care products primarily in the United States.

PCYN

US$0.18

7D

0%

1Y

-17.6%

Alterola Biotech

Market Cap: US$1.5m

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

ABTI

US$0.001

7D

0%

1Y

-69.7%

Salarius Pharmaceuticals

Market Cap: US$1.4m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

SLRX

US$0.83

7D

7.7%

1Y

-79.0%

Kaya Holdings

Market Cap: US$1.4m

A vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics and medical cannabis dispensaries primarily in the United States.

KAYS

US$0.034

7D

-11.7%

1Y

-13.9%

Ocean Biomedical

Market Cap: US$1.4m

A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.

OCEA

US$0.0086

7D

-15.5%

1Y

-99.5%

Restart Life Sciences

Market Cap: CA$2.0m

Through its subsidiaries, operates as a biotechnology company worldwide.

HEAL

CA$0.06

7D

-14.3%

1Y

-60.0%

Osteopore

Market Cap: AU$2.2m

A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, the United States, Malaysia, Indonesia, Netherlands, Thailand, Australia, and internationally.

OSX

AU$0.013

7D

-7.1%

1Y

-83.5%

Page 48 of 65